RCMU
ROIV icon

Rokos Capital Management (UK)’s Roivant Sciences ROIV Stock Holding History

Rokos Capital Management (UK)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-300,000
Closed -$2.24M – 106
2023
Q1 		$2.24M Buy
+300,000
New +$2.47M 0.17% 50

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rokos Capital Management (UK)'s ROIV Position: Q2 2023 in Review

Rokos Capital Management (UK) sold out of Roivant Sciences (ROIV) in Q2 2023, closing a stake of 300,000 shares — an estimated $2.24M sold.

Rokos Capital Management (UK) first reported a position in ROIV in Q1 2023 and held it in 1 quarter. The position peaked at $2.24M in Q1 2023. 181 funds tracked by Wall St. Rank hold ROIV as of Q2 2023.

  • Rokos Capital Management (UK) reported no remaining Roivant Sciences position as of Q2 2023 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 300,000 Roivant Sciences shares in Q2 2023, an estimated $2.24M.
  • Rokos Capital Management (UK) first reported a position in Roivant Sciences in Q1 2023 and held it in 1 quarter.
  • Rokos Capital Management (UK)'s Roivant Sciences position peaked at $2.24M in Q1 2023.
  • 181 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2023.

Based on Rokos Capital Management (UK)'s 13F filing for Q2 2023, filed 14 Aug 2023.